
Kenota
Develops next generation medical diagnostic tools.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor | €0.0 | round |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
* | $9.0m | Series A | |
Total Funding | 000k |
Related Content
Kenota is a pioneering company in the healthcare sector, specifically focusing on allergy testing. The company has developed an innovative system that allows for lab-quality IgE allergy testing directly within clinics. This enables healthcare providers to quickly and accurately diagnose allergies in a single visit, enhancing the patient-physician connection. Kenota's primary clients are allergy professionals and clinics that seek to improve their diagnostic capabilities. Operating in the medical diagnostics market, Kenota's business model revolves around providing advanced testing tools and technology to healthcare providers. The company generates revenue through the sale of its testing systems and related services. Kenota has been actively engaged with regulatory bodies like the FDA to ensure the safety, effectiveness, and compliance of its products. The company is led by experienced professionals with extensive backgrounds in laboratory and regulated businesses.
Keywords: allergy testing, IgE, diagnostics, healthcare, clinics, FDA compliance, patient care, medical technology, revenue model, innovation.